Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TLL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100288911 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARHGEF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf71 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1909 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
URM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRIG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF821 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3TC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
A1BG-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH2D5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERGIC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNAB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR205HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on